Clinical Trial Update: Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson&Apos;s Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating cholinesterase inhibitors to slow progression of visual hallucinations in Parkinson's disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Parkinson's Disease | Phase 4 | Status: TERMINATED